Your browser doesn't support javascript.
loading
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression.
Stock, Carmel J W; Hoyles, Rachel K; Daccord, Cecile; Kokosi, Maria; Visca, Dina; De Lauretis, Angelo; Alfieri, Veronica; Kouranos, Vasilis; Margaritopoulos, George; George, Peter M; Molyneaux, Philip L; Chua, Felix; Maher, Toby M; Abraham, David J; Ong, Voon; Donovan, Jackie; Sestini, Piersante; Denton, Christopher P; Wells, Athol U; Renzoni, Elisabetta A.
Afiliação
  • Stock CJW; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Hoyles RK; Oxford Centre for Respiratory Medicine, Oxford University Hospitals, Oxford, UK.
  • Daccord C; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Kokosi M; Division of Respiratory Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
  • Visca D; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • De Lauretis A; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Alfieri V; Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
  • Kouranos V; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Margaritopoulos G; Unita' Operativa Malattie Respiratorie, Ospedale Guido Salvini, Milan, Italy.
  • George PM; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Molyneaux PL; Respiratory Disease and Lung Function Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Chua F; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Maher TM; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Abraham DJ; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Ong V; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Donovan J; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Sestini P; Interstitial Lung Disease Unit, Royal Brompton Hospital, National Heart and Lung Institute, Imperial College, London, UK.
  • Denton CP; Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, London, UK.
  • Wells AU; Centre for Rheumatology and Connective Tissue Diseases, Royal Free and University College Medical School, London, UK.
  • Renzoni EA; Department of Biochemistry, Royal Brompton Hospital, London, UK.
Respirology ; 26(5): 461-468, 2021 05.
Article em En | MEDLINE | ID: mdl-33336433
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Queratina-19 / Pulmão / Antígenos de Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Doenças Pulmonares Intersticiais / Queratina-19 / Pulmão / Antígenos de Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article